Fancl (4921) Q1 2025 earnings summary

Executive summary

• Net sales for the quarter decreased 4.1% year-over-year to ¥26,042 million, with declines in both cosmetics and nutritional supplements segments.

• Operating income dropped 18.1% to ¥2,621 million, and net income attributable to owners fell 23.6% to ¥1,673 million.

• Comprehensive income declined 21.3% to ¥1,697 million compared to the same quarter last year.

Financial highlights

• Gross profit was ¥8,154 million, down from ¥8,608 million year-over-year.

• Selling, general and administrative expenses totaled ¥15,266 million.

• Earnings per share decreased to ¥13.83 from ¥18.11 year-over-year.

• Shareholders’ equity ratio improved to 81.0% from 72.2% at the end of the previous fiscal year.

Outlook and guidance

• Full-year and interim consolidated forecasts remain unchanged: projected net sales of ¥118,500 million (+6.9%), operating income of ¥14,500 million (+15.3%), and net income attributable to owners of ¥10,000 million (+13.2%).

• No dividends are planned for the fiscal year, conditional on the completion of the tender offer by Kirin Holdings.